Requirement for both H-2Db and H-2Kd for the induction of diabetes by the promiscuous CD8+ T cell clonotype A14

被引:25
作者
Takaki, T
Lieberman, SM
Holl, TM
Han, BY
Santamaria, P
Serreze, DV
DiLorenzo, TP
机构
[1] Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA
[2] Yeshiva Univ Albert Einstein Coll Med, Dept Med, Div Endocrinol, Bronx, NY 10461 USA
[3] Jackson Lab, Bar Harbor, ME 04609 USA
[4] Univ Calgary, Hlth Sci Ctr, Fac Med, Dept Microbiol & Infect Dis, Calgary, AB, Canada
[5] Univ Calgary, Hlth Sci Ctr, Fac Med, Julia McFarlane Diabetes Res Ctr, Calgary, AB, Canada
关键词
D O I
10.4049/jimmunol.173.4.2530
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The NOD mouse is a model for autoimmune type I diabetes in humans. CD8(+) T cells are essential for the destruction of the insulin-producing pancreatic beta cells characterizing this disease. AI4 is a pathogenic CD8(+) T cell clone, isolated from the islets of a 5-wk-old female NOD mouse, which is capable of mediating overt diabetes in the absence of CD4(+) T cell help. Recent studies using MHC-congenic NOD mice revealed marked promiscuity of the AI4 TCR, as the selection of this clonotype can be influenced by multiple MHC molecules, including some class 11 variants. The present work was designed, in part, to determine whether similar promiscuity also characterizes the effector function of mature AI4 CTL. Using splenocyte and bone marrow disease transfer models and in vitro islet-killing assays, we report that efficient recognition and destruction of beta cells by AI4 requires the beta cells to simultaneously express both H-2D(b) and H-2K(d) class I MHC molecules. The ability of the AI4 TCR to interact with both H-2D(b) and H-2K(d) was confirmed using recombinant peptide libraries. This approach also allowed us to define a mimotope peptide recognized by AI4 in an H-2D(b)-restricted manner. Using ELISPOT and mimotope/H-2D(b) tetramer analyses, we demonstrate for the first time that AI4 represents a readily detectable T cell population in the islet infiltrates of prediabetic NOD mice. Our identification of a ligand for AI4-like T cells will facilitate further characterization and manipulation of this pathogenic and promiscuous T cell population.
引用
收藏
页码:2530 / 2541
页数:12
相关论文
共 58 条
[11]   Major histocompatibility complex class I-restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor α chain gene rearrangement [J].
DiLorenzo, TP ;
Graser, RT ;
Ono, T ;
Christianson, GJ ;
Chapman, HD ;
Roopenian, DC ;
Nathenson, SG ;
Serreze, DV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (21) :12538-12543
[12]   During the early prediabetic period in NOD mice, the pathogenic CD8+ T-cell population comprises multiple antigenic specificities [J].
DiLorenzo, TP ;
Lieberman, SM ;
Takaki, T ;
Honda, S ;
Chapman, HD ;
Santamaria, P ;
Serreze, DV ;
Nathenson, SG .
CLINICAL IMMUNOLOGY, 2002, 105 (03) :332-341
[13]   ALLELE-SPECIFIC MOTIFS REVEALED BY SEQUENCING OF SELF-PEPTIDES ELUTED FROM MHC MOLECULES [J].
FALK, K ;
ROTZSCHKE, O ;
STEVANOVIC, S ;
JUNG, G ;
RAMMENSEE, HG .
NATURE, 1991, 351 (6324) :290-296
[14]  
Fleischhauer K, 1996, J IMMUNOL, V157, P787
[15]   Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions [J].
Graser, RT ;
DiLorenzo, TP ;
Wang, FM ;
Christianson, GJ ;
Chapman, HD ;
Roopenian, DC ;
Nathenson, SG ;
Serreze, DV .
JOURNAL OF IMMUNOLOGY, 2000, 164 (07) :3913-3918
[16]   MHC characterization of ALR and ALS mice: respective similarities to the NOD and NON strains [J].
Graser, RT ;
Mathews, CE ;
Leiter, EH ;
Serreze, DV .
IMMUNOGENETICS, 1999, 49 (7-8) :722-726
[17]   NIT-1, A PANCREATIC BETA-CELL LINE ESTABLISHED FROM A TRANSGENIC NOD LT MOUSE [J].
HAMAGUCHI, K ;
GASKINS, HR ;
LEITER, EH .
DIABETES, 1991, 40 (07) :842-849
[18]   Probing degeneracy in T-cell recognition using peptide combinatorial libraries [J].
Hemmer, B ;
Vergelli, M ;
Pinilla, C ;
Houghten, R ;
Martin, R .
IMMUNOLOGY TODAY, 1998, 19 (04) :163-168
[19]   Maintaining the norm: T-CELL homeostasis [J].
Jameson, SC .
NATURE REVIEWS IMMUNOLOGY, 2002, 2 (08) :547-556
[20]   SELECTIVE REJECTION OF H-2-DEFICIENT LYMPHOMA VARIANTS SUGGESTS ALTERNATIVE IMMUNE DEFENSE STRATEGY [J].
KARRE, K ;
LJUNGGREN, HG ;
PIONTEK, G ;
KIESSLING, R .
NATURE, 1986, 319 (6055) :675-678